Naproxen Bp Milpharm

Naproxen, the active ingredient in Naproxen Bp Milpharm, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for adults with conditions such as osteoarthritis, rheumatoid arthritis and dysmenorrhea.

GNH USA supplies Naproxen Bp Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain in musculoskeletal and gynecologic conditions.

- Osteoarthritis: alleviates joint pain and improves mobility. - Rheumatoid arthritis: decreases joint inflammation and swelling. - Dysmenorrhea: relieves menstrual cramps and associated discomfort. - Acute pain: provides rapid analgesia for injuries or postoperative pain. - Fever: lowers elevated body temperature in febrile states.

Adverse reactions may range from mild to serious and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort, such as dyspepsia or heartburn. - Nausea or vomiting. - Headache. - Dizziness. - Mild skin rash. - Elevated blood pressure.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or reduced kidney function. - Hepatotoxicity with elevated liver enzymes. - Severe hypersensitivity reactions, including anaphylaxis. - Cardiovascular events such as myocardial infarction or stroke. - Thrombotic thrombocytopenic purpura (very rare).

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

- Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Evaluate renal function: use caution in those with existing kidney disease. - Monitor hepatic enzymes: discontinue if significant liver injury occurs. - Check cardiovascular status: avoid in patients with uncontrolled hypertension or recent cardiac events. - Review concomitant medications: avoid combining with other NSAIDs or anticoagulants without supervision. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Naproxen may alter the efficacy or safety of several co‑administered drugs.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - Certain antihypertensives (e.g., ACE inhibitors, diuretics): may reduce blood‑pressure control.

Moderate Interactions (Monitor Closely): - Other NSAIDs or aspirin: heightened GI and renal adverse effects. - Lithium: naproxen can raise lithium serum levels. - Methotrexate: reduced clearance may increase toxicity. - Corticosteroids: combined use raises ulcer risk.